Literature DB >> 20966069

Albumin-based microbubbles bind up-regulated scavenger receptors following vascular injury.

Daniel R Anderson1, Michael J Duryee, Rajeev K Anchan, Robert P Garvin, Michael D Johnston, Thomas R Porter, Geoffrey M Thiele, Lynell W Klassen.   

Abstract

We have shown previously that perfluorocarbon-exposed sonicated dextrose albumin (PESDA) microbubbles bind to injured vascular tissue and can be detected with ultrasound imaging techniques. Prior studies have shown that scavenger receptors (SRs) are regulators of innate and adaptive immune responses and are involved in the progression of vascular disease such as atherosclerosis. In this study, we sought to determine the molecular mechanism of PESDA binding to balloon-injured vasculature. RT-PCR analysis of angioplastied aortas demonstrated a significantly (p ≤ 0.01) increased expression of SRs. Binding to SRs was confirmed using SR-expressing CHO cells, and this binding was blocked by competitive inhibition with the SR-binding ligands oxidized LDL and malondialdehyde-acetaldehyde-modified LDL. Confocal imaging confirmed the co-localization of PESDA microbubbles to CD36, SRB-1, and Toll-like receptor 4, but not to monocytes/macrophages. This study demonstrates that PESDA binds to SRs and that this binding is in major part dependent upon the oxidized nature of PESDA microbubble shell proteins. The extent of SR mRNA expression was increased with injury and associated with microbubble retention as defined by scanning electron microscopy and immunohistochemistry. These findings clarify the mechanisms of how albumin-based microbubbles bind to injured and inflamed vasculature and further support the potential of this imaging technique to detect early vascular innate inflammatory pathophysiologic processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20966069      PMCID: PMC3003363          DOI: 10.1074/jbc.M110.134809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes.

Authors:  J R Lindner; J Song; F Xu; A L Klibanov; K Singbartl; K Ley; S Kaul
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

Review 2.  Innate and adaptive immunity in the pathogenesis of atherosclerosis.

Authors:  Göran K Hansson; Peter Libby; Uwe Schönbeck; Zhong-Qun Yan
Journal:  Circ Res       Date:  2002-08-23       Impact factor: 17.367

3.  Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.

Authors:  Yury I Miller; Suganya Viriyakosol; Christoph J Binder; James R Feramisco; Theo N Kirkland; Joseph L Witztum
Journal:  J Biol Chem       Date:  2002-11-06       Impact factor: 5.157

4.  Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes.

Authors:  J R Lindner; M P Coggins; S Kaul; A L Klibanov; G H Brandenburger; K Ley
Journal:  Circulation       Date:  2000-02-15       Impact factor: 29.690

Review 5.  Crosstalk pathways between Toll-like receptors and the complement system.

Authors:  George Hajishengallis; John D Lambris
Journal:  Trends Immunol       Date:  2010-02-10       Impact factor: 16.687

Review 6.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-14       Impact factor: 29.690

Review 7.  Inflammation and atherosclerosis: role of C-reactive protein in risk assessment.

Authors:  Peter Libby; Paul M Ridker
Journal:  Am J Med       Date:  2004-03-22       Impact factor: 4.965

8.  Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.

Authors:  S Matthijs Boekholdt; Willem R P Agema; Ron J G Peters; Aeilko H Zwinderman; Ernst E van der Wall; Pieter H Reitsma; John J P Kastelein; J Wouter Jukema
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

9.  Influence of C3 deficiency on atherosclerosis.

Authors:  Chiara Buono; Carolyn E Come; Joseph L Witztum; Graham F Maguire; Philip W Connelly; Michael Carroll; Andrew H Lichtman
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

Review 10.  Initiation of complement activation following oxidative stress. In vitro and in vivo observations.

Authors:  Melanie L Hart; Mary C Walsh; Gregory L Stahl
Journal:  Mol Immunol       Date:  2004-06       Impact factor: 4.407

View more
  5 in total

Review 1.  Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

Authors:  Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

Review 2.  Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems.

Authors:  Polina G Rudakovskaya; Roman A Barmin; Pavel S Kuzmin; Elena P Fedotkina; Alexander N Sencha; Dmitry A Gorin
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

3.  Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.

Authors:  Geoffrey M Thiele; Michael J Duryee; Carlos D Hunter; Bryant R England; Benjamin S Fletcher; Eric C Daubach; Taylor P Pospisil; Lynell W Klassen; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2020-03-27       Impact factor: 4.932

4.  Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease.

Authors:  Michael J Duryee; Dahn L Clemens; Patrick J Opperman; Geoffrey M Thiele; Logan M Duryee; Robert P Garvin; Daniel R Anderson
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

5.  Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging.

Authors:  Alisa Umanskaya; Gaetano Santulli; Wenjun Xie; Daniel C Andersson; Steven R Reiken; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.